Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000909012-08-001243
Filing Date
2008-12-03
Accepted
2008-12-03 14:53:37
Documents
1
Group Members
JOSEPH EDELMAN

Document Format Files

Seq Description Document Type Size
1 t304771.txt SC 13D/A 20265
  Complete submission text file 0000909012-08-001243.txt   22255
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Subject) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: SC 13D/A | Act: 34 | File No.: 005-83127 | Film No.: 081227371
SIC: 2834 Pharmaceutical Preparations

Mailing Address 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 646-205-5340
PERCEPTIVE ADVISORS LLC (Filed by) CIK: 0001224962 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A